Since 2020~

August 2020: Founded a laboratory based on patents held by Chung-Ang University
October 2020: Registered as a medical device manufacturer
March 2022: Certified as a venture company
June 2024: Established the R&D department

- The company received the highest patent valuation from the Technology Assurance Fund. It was also the recipient of several government grants and awards, including support programmes from the Ministry of SMEs and Startups and the Ministry of Environment.
- Additionally, the company has published over 130 SCI papers and registered 25 patents. In 2023, the company generated sales revenue of 176,000,000 KRW.

Drug Delivery System

Lipid Nanoparticles, Organic/Inorganic Nanoparticles

Medical Materials
 

Antimicrobial catheter/ tubing/ stent

Medical Devices
 

Antimicrobial surgical devices

Antimicrobial
Antiviral Evaluation Services

​Antimicrobial Evaluation

Skincare Product Development

Developed a skincare product containing Oxygen nanoliposome (Mist formulation)

Business Introduction

Domestic Activities

NanoMedicine Co., Ltd. has established a corporate network with companies in the domestic bio industry, medical device manufacturers, university hospitals, and local hospitals.

International Activities

NanoMedicine Co., Ltd. and the Nano Medicine Research Lab at Chung-Ang University are participants in international testing organizations for ISO20814 and ISO TC229 (Nanotechnologies). They also collaborate internationally with the U.S. Department of Commerce and the National Institute of Standards and Technology (NIST).